The industrial trend gathers in Hangzhou, and the top biopharmaceutical professional exhibition lands heavily

Based on the strategic deployment of the national "Bioeconomy Development Plan" and "Healthy China 2030", and seizing the opportunity of biopharmaceuticals becoming a national strategic emerging pillar industry, the 2026 Hangzhou International Biopharmaceutical Industry Expo, jointly hosted by authoritative institutions in the domestic life science, biotechnology, and pharmaceutical equipment industries, will grandly kick off at the Hangzhou Convention and Exhibition Center from December 16 to 18, 2026.

As a leading and highly internationalized biopharmaceutical industry chain professional exhibition in the southern wing of the Yangtze River Delta, this expo is based on the advantages of the Hangzhou biopharmaceutical industry cluster, relying on the large modern exhibition hall of the Hangzhou Convention and Exhibition Center, convenient transportation by air and rail, and one-stop smart exhibition service system. It aims to build an international industrial hub that integrates fruit display, academic seminars, business docking, industry investment promotion, and investment and financing negotiations, helping domestic biopharmaceutical enterprises connect with global resources, promoting the deep integration of cutting-edge technologies, innovative pipelines, industrial chains, and supply chains at home and abroad, and accelerating the landing of new quality productivity in biopharmaceuticals through exhibitions.

As a highland of biopharmaceutical innovation in the Yangtze River Delta, Hangzhou has built a complete industrial ecosystem covering innovative drug research and development, pilot scale production, large-scale production, clinical translation, and supporting consumables and equipment. It has gathered a large number of biopharmaceutical companies, CRO/CDMO platforms, research institutes, and biopharmaceutical industry parks; As the core carrier of Hangzhou's exhibition economy, the Hangzhou Grand Convention and Exhibition Center has a large column free exhibition hall, complete clean facilities, and international conference facilities, which can fully meet the professional needs of biopharmaceutical enterprises for high standard special equipment exhibitions, large-scale academic forums, and closed sample exhibitions. It provides first-class hardware support and full process operation services for industry events.

Full chain multi-dimensional exhibition area, covering the entire track of biopharmaceutical upstream and downstream

This expo plans to have a professional exhibition area of over 30000 square meters, with ten segmented characteristic exhibition areas, gathering more than 800 leading enterprises and specialized new biotechnology companies from home and abroad to participate. It fully connects the entire industry chain of biopharmaceutical research and development, production, quality control, and supporting facilities, and exhibits cover cutting-edge achievements in all categories of the industry

1. Innovative Biopharmaceutical Exhibition Area: Frontier pipeline products such as single/bispecific antibodies, ADC drugs, cell and gene therapy CGT, mRNA nucleic acid drugs, recombinant proteins, peptide drugs, rare disease biologics, etc;

2. Exhibition area for active pharmaceutical ingredients and biological intermediates: fermentation raw materials, medicinal amino acids, enzyme preparations, culture media, natural biological extracts, and characteristic biocatalytic intermediates;

3. CDMO/CRO/CMO one-stop service exhibition area: drug development outsourcing, preclinical research, pilot production, process development, compliance registration, testing and analysis full chain services;

4. Biopharmaceutical Intelligent Equipment Exhibition Area: Bioreactors, Chromatography Purification Systems, Disposable Bioprocess Equipment, Aseptic Filling, Online Quality Control Testing Instruments, Automated Cell Culture Equipment;

5. Laboratory and analytical instrument exhibition area: chromatography-mass spectrometry equipment, biological sequencer, cell analyzer, sterile testing, laboratory automation system;

6. Exhibition area for pharmaceutical excipients, packaging materials, and clean engineering: bio specific pharmaceutical excipients, sterile packaging, isolators, overall solutions for clean workshops, and environmentally friendly water treatment equipment;

7. Special exhibition area for synthetic biology: gene editing, microbial synthesis, non food biomanufacturing, biobased new material technology;

8. Digital pharmaceutical exhibition area: AI drug research and development, intelligent manufacturing MES system, digital twin factory, pharmaceutical enterprise digital compliance management platform;

9. Park and Investment and Financing Exhibition Area: Yangtze River Delta and National Biomedical Industry Parks, Industrial Funds, VC/PE Investment Institutions, Biomedical Mergers and Acquisitions Services;

10. International Enterprise Zone: A centralized display area for multinational biopharmaceutical companies from Europe, America, Japan, South Korea, Southeast Asia, and overseas high-end equipment and reagent brands.

The exhibition is expected to attract over 40000 precise professional visitors from around the world, including pharmaceutical research and development/production procurement leaders, clinical pharmacy experts from hospitals, research groups from universities, investment promotion leaders from industrial parks, pharmaceutical distribution companies, overseas purchasers, and representatives from investment and financing institutions, to achieve efficient and precise supply-demand matching.

Over 30 concurrent high-end forums to gauge the global trend of the biopharmaceutical industry

The exhibition adopts a dual line integration mode of "exhibition+summit", including Hangzhou Biopharmaceutical Innovation Summit, CGT (Cell and Gene Therapy) Drug Development and Industrialization Forum, ADC (Antibody Conjugated Drugs) and XDC Innovation Forum, Synthetic Biology and Green Biological Manufacturing Forum, Biopharmaceutical Digital Factory Construction and Practice Salon, Hangzhou Pharmaceutical Port Project Matchmaking Conference, International Buyer Procurement Negotiation Conference, and more than 30 parallel sub forums, gathering academicians, industry leading enterprise CEOs, top global R&D scientists, drug regulatory review experts, and capital investors to conduct in-depth discussions around industry core hotspots:

-Industrialization, quality control, and compliance supervision of cell and gene therapy;

-ADC、 Breakthrough in the commercial production process of dual antibody and nucleic acid drugs;

-AI empowers the development of new drugs and the large-scale application of synthetic biology;

-Green and low-carbon production and environmental protection transformation of biopharmaceuticals;

-Innovative drugs going global through BD cooperation, international registration, and global market layout;

-Intelligent upgrading of biomanufacturing and replacement of traditional stainless steel equipment with disposable processes;

-Collaboration of the biopharmaceutical industry in the Yangtze River Delta, investment attraction in industrial parks, and interpretation of industrial policies;

-Biomedical investment and financing, early project incubation, and clinical translation.

The forum synchronously sets up multiple closed door docking meetings, overseas enterprise special negotiation meetings, industry university research achievement transformation signing ceremonies, new product launch conferences, and industry annual award ceremonies, creating a high-level communication platform for ideological collision, resource exchange, and project implementation.

Exhibition has multiple values, empowering enterprises to develop in all dimensions

1. Brand display highland: Focusing on showcasing new technologies, products, and processes of enterprises to professional groups at home and abroad, establishing industry brand influence;

2. Precise business matching: Targeted invitation of upstream and downstream purchasers, overseas agents, medical institutions, on-site one-on-one business negotiations, and rapid expansion of customer channels;

3. Frontier technology exchange: Zero distance docking with academicians, experts, and industry leaders to grasp the latest technological iterations and policy trends in global biopharmaceuticals;

4. Bridge for the transformation of industry, academia, and research: Build a cooperation channel between enterprises, universities, and research institutes to promote the industrialization of laboratory achievements;

5. Industrial investment carrier: Concentrated promotion of biopharmaceutical parks in various regions to attract high-quality biopharmaceutical projects to settle in Hangzhou and the Yangtze River Delta;

6. International Cooperation Window: Open up two-way communication channels for biopharmaceuticals between China and foreign countries, and assist local enterprises in going global and introducing advanced technology and capital from overseas.

Exhibition and visit reservations have been fully launched, and we sincerely invite industry colleagues from around the world to gather in Hangzhou

At present, the registration channels for participating in the 2026 Hangzhou International Biopharmaceutical Industry Expo, booking forum seats, and pre registration for professional visitors have been fully opened. The exhibition organizing committee will launch special supporting services such as group exhibition discounts, park exhibition special vehicles, overseas customer reception, and business matching appointments to reduce the cost of enterprise participation and exhibition, and improve the effectiveness of participation.

From December 16th to 18th, 2026, on the banks of the Qiantang River, at the Hangzhou Convention and Exhibition Center, the 2026 Hangzhou International Biopharmaceutical Industry Expo invites global biopharmaceutical practitioners to gather in Hangzhou to explore new opportunities in the biopharmaceutical economy and build an innovative ecosystem for the biopharmaceutical industry together!

Contact Information for Consultation

Organizing Committee Hotline: 021-5601 1108 18721670787

Full chain multi-dimensional exhibition area, covering the entire track of biopharmaceutical upstream and downstream

This expo plans to have a professional exhibition area of over 30000 square meters, with ten segmented characteristic exhibition areas, gathering more than 800 leading enterprises and specialized new biotechnology companies from home and abroad to participate. It fully connects the entire industry chain of biopharmaceutical research and development, production, quality control, and supporting facilities, and exhibits cover cutting-edge achievements in all categories of the industry

1. Innovative Biopharmaceutical Exhibition Area: Frontier pipeline products such as single/bispecific antibodies, ADC drugs, cell and gene therapy CGT, mRNA nucleic acid drugs, recombinant proteins, peptide drugs, rare disease biologics, etc;

2. Exhibition area for active pharmaceutical ingredients and biological intermediates: fermentation raw materials, medicinal amino acids, enzyme preparations, culture media, natural biological extracts, and characteristic biocatalytic intermediates;

3. CDMO/CRO/CMO one-stop service exhibition area: drug development outsourcing, preclinical research, pilot production, process development, compliance registration, testing and analysis full chain services;

4. Biopharmaceutical Intelligent Equipment Exhibition Area: Bioreactors, Chromatography Purification Systems, Disposable Bioprocess Equipment, Aseptic Filling, Online Quality Control Testing Instruments, Automated Cell Culture Equipment;

5. Laboratory and analytical instrument exhibition area: chromatography-mass spectrometry equipment, biological sequencer, cell analyzer, sterile testing, laboratory automation system;

6. Exhibition area for pharmaceutical excipients, packaging materials, and clean engineering: bio specific pharmaceutical excipients, sterile packaging, isolators, overall solutions for clean workshops, and environmentally friendly water treatment equipment;

7. Special exhibition area for synthetic biology: gene editing, microbial synthesis, non food biomanufacturing, biobased new material technology;

8. Digital pharmaceutical exhibition area: AI drug research and development, intelligent manufacturing MES system, digital twin factory, pharmaceutical enterprise digital compliance management platform;

9. Park and Investment and Financing Exhibition Area: Yangtze River Delta and National Biomedical Industry Parks, Industrial Funds, VC/PE Investment Institutions, Biomedical Mergers and Acquisitions Services;

10. International Enterprise Zone: A centralized display area for multinational biopharmaceutical companies from Europe, America, Japan, South Korea, Southeast Asia, and overseas high-end equipment and reagent brands.

• Telephone:18721670787
• Contact:Organizing Committee
• Mobile:18721670787
• Address:West of the intersection of Meishi Line and Yannan Line in Xiaoshan District, Hangzhou City

The information on this site comes from the network and related members, and the website has done its duty to review it. Due to the uncontrollability of the process of organizing the exhibition, some of the exhibition information in the station may change the subject matter, Extending or cancelling the event, please exhibitors and visitors must check with each other again before exhibiting! All the exhibitions in this site are not hosted/co-organized or organized, if there are any disputes during the exhibition, please hold the main responsibility of the exhibition organization! QQ Email: 523138820@qq.com WeChat: 523138820 Mobile: 15313206870